WO2001093831A3 - Low carbohydrate compositions, kits thereof, and methods of use - Google Patents

Low carbohydrate compositions, kits thereof, and methods of use Download PDF

Info

Publication number
WO2001093831A3
WO2001093831A3 PCT/US2001/017716 US0117716W WO0193831A3 WO 2001093831 A3 WO2001093831 A3 WO 2001093831A3 US 0117716 W US0117716 W US 0117716W WO 0193831 A3 WO0193831 A3 WO 0193831A3
Authority
WO
WIPO (PCT)
Prior art keywords
methylsulfonylmethane
composition
present
chondroprotective
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/017716
Other languages
French (fr)
Other versions
WO2001093831A2 (en
Inventor
Matthew Thomas Heisey
Kenneth Norman Kern
Kris Eugene Spence
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/759,965 external-priority patent/US20020132780A1/en
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to AU2001269730A priority Critical patent/AU2001269730A1/en
Priority to CA002408610A priority patent/CA2408610A1/en
Priority to MXPA02011939A priority patent/MXPA02011939A/en
Priority to EP01948259A priority patent/EP1289532A2/en
Priority to JP2002501404A priority patent/JP2003535120A/en
Priority to BR0111292-9A priority patent/BR0111292A/en
Publication of WO2001093831A2 publication Critical patent/WO2001093831A2/en
Publication of WO2001093831A3 publication Critical patent/WO2001093831A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to compositions, kits, and methods utilized for the treatment of joint dysfunction, bone dysfunction, and / or inflammation. The composition utilized herein are useful for those mammals experiencing painful or debilitating joint, bone, or inflammatory conditions, and are particularly suited for mammals which are diabetic or at risk for diabetes, as well as those desiring or requiring conveniently dosed chondroprotective compositions having low carbohydrate content, low caloric value and / or having a low glycemic index. In particular, the present compositions comprise: a) a chondroprotective agent selected from gelatin, cartilage, aminosugars, glycosaminoglycans, methylsulfonylmethane, precursors of methylsulfonylmethane, S-adenosylmethionine, and mixtures thereof; b) a sweetening agent other than glucose, dextrose, sucrose, and fructose; and c) at least about 10 % water, by weight of the composition. In an alternative embodiment of the present invention, the present compositions comprise: a) a chondroprotective agent selected from gelatin, cartilage, aminosugars, glycosaminoglycans, methylsulfonylmethane, precursors of methylsulfonylmethane, S-adenosylmethionine, salts thereof, and mixtures thereof; and b) a sweetening agent other than glucose, dextrose, sucrose, and fructose; wherein the composition is substantially free of aspartame.
PCT/US2001/017716 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use Ceased WO2001093831A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2001269730A AU2001269730A1 (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use
CA002408610A CA2408610A1 (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use
MXPA02011939A MXPA02011939A (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use.
EP01948259A EP1289532A2 (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use
JP2002501404A JP2003535120A (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of using the same
BR0111292-9A BR0111292A (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits of these and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
US09/586,514 2000-06-02
US09/759,965 2001-01-12
US09/759,965 US20020132780A1 (en) 2001-01-12 2001-01-12 Low carbohydrate compositions, kits thereof, and methods of use

Publications (2)

Publication Number Publication Date
WO2001093831A2 WO2001093831A2 (en) 2001-12-13
WO2001093831A3 true WO2001093831A3 (en) 2002-04-25

Family

ID=27079730

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/017716 Ceased WO2001093831A2 (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use

Country Status (8)

Country Link
EP (1) EP1289532A2 (en)
JP (1) JP2003535120A (en)
CN (1) CN1438892A (en)
AU (1) AU2001269730A1 (en)
BR (1) BR0111292A (en)
CA (1) CA2408610A1 (en)
MX (1) MXPA02011939A (en)
WO (1) WO2001093831A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431937B2 (en) * 2001-03-30 2008-10-07 L'oreal, S.A. Compositions comprising at least one aminated C5-C7 saccharide unit, and their use for the protection and/or repair of keratinous fibers
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
AU2003903037A0 (en) * 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
AU2006318781B2 (en) * 2005-11-23 2012-11-01 The Coca-Cola Company Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
WO2009114650A1 (en) * 2008-03-11 2009-09-17 Chakshu Research, Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
KR101314322B1 (en) * 2009-09-28 2013-10-02 박유신 Composition for treating and preventing cartilage and connective tissue involved desease
CN105209120A (en) 2013-03-15 2015-12-30 纽约大学 Citrate containing beverage
US20170027976A1 (en) * 2014-04-14 2017-02-02 Methylation Sciences International Srl Novel ademetionine formulations
JP6528588B2 (en) * 2014-08-19 2019-06-12 大正製薬株式会社 Solid preparation
KR101957502B1 (en) * 2018-08-17 2019-03-12 이승훈 Composition for preventing or improving obsity, fatty liver and diabetes comprising Methyl Sulfonyl Methane: Dimethyl Sulfone

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387A1 (en) * 1971-01-26 1972-08-17 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Compns of glucosamine hydrochloride and anti-rheumatic - agent - for treatment of arthrosis and arthritis,with reduced toxicit
JPH0733668A (en) * 1993-07-21 1995-02-03 Maruha Corp Bone strengthening promoter
EP0704216A1 (en) * 1994-09-28 1996-04-03 Ibsa - Institut Biochimique S.A. Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
US5993880A (en) * 1998-10-01 1999-11-30 Kraft Foods Inc. Non-staining, acid-stable, cold-water-soluble, edible green color and compositions for preparing acidic foods and beverages
EP0982034A1 (en) * 1998-08-26 2000-03-01 aristavet Veterinärspezialitäten GmbH & Co. KG Composition comprising glucosamine and an extract of Perna canaliculus
GB2345247A (en) * 1998-12-23 2000-07-05 Sueddeutsche Kalkstickstoff Pyruvic acid formulations
WO2000078320A1 (en) * 1999-06-22 2000-12-28 Joint Juice Incorporated Cartilage enhancing food supplements and methods of preparing the same
JP2001000158A (en) * 1999-06-18 2001-01-09 Suntory Ltd Method for producing low-acid beverage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4070844B2 (en) * 1997-08-20 2008-04-02 株式会社ヤクルト本社 Magnesium-containing oral composition
JP2971855B1 (en) * 1998-06-22 1999-11-08 明治乳業株式会社 Method for producing flavored amino acid-containing food
JP4300652B2 (en) * 1998-09-21 2009-07-22 大正製薬株式会社 Oral solid formulation
JP2000175648A (en) * 1998-12-11 2000-06-27 Sanei Gen Ffi Inc Sweet composition containing whey minerals
JP2000281562A (en) * 1999-03-30 2000-10-10 Taisho Pharmaceut Co Ltd Gel composition
JP2000290199A (en) * 1999-03-31 2000-10-17 Taisho Pharmaceut Co Ltd Oral pharmaceutical composition

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387A1 (en) * 1971-01-26 1972-08-17 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Compns of glucosamine hydrochloride and anti-rheumatic - agent - for treatment of arthrosis and arthritis,with reduced toxicit
JPH0733668A (en) * 1993-07-21 1995-02-03 Maruha Corp Bone strengthening promoter
EP0704216A1 (en) * 1994-09-28 1996-04-03 Ibsa - Institut Biochimique S.A. Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
EP0982034A1 (en) * 1998-08-26 2000-03-01 aristavet Veterinärspezialitäten GmbH & Co. KG Composition comprising glucosamine and an extract of Perna canaliculus
US5993880A (en) * 1998-10-01 1999-11-30 Kraft Foods Inc. Non-staining, acid-stable, cold-water-soluble, edible green color and compositions for preparing acidic foods and beverages
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
GB2345247A (en) * 1998-12-23 2000-07-05 Sueddeutsche Kalkstickstoff Pyruvic acid formulations
JP2001000158A (en) * 1999-06-18 2001-01-09 Suntory Ltd Method for producing low-acid beverage
WO2000078320A1 (en) * 1999-06-22 2000-12-28 Joint Juice Incorporated Cartilage enhancing food supplements and methods of preparing the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199515, Derwent World Patents Index; Class B03, AN 1995-110552, XP002187629 *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 16 8 May 2001 (2001-05-08) *
See also references of EP1289532A2 *

Also Published As

Publication number Publication date
WO2001093831A2 (en) 2001-12-13
CN1438892A (en) 2003-08-27
JP2003535120A (en) 2003-11-25
MXPA02011939A (en) 2003-04-22
AU2001269730A1 (en) 2001-12-17
CA2408610A1 (en) 2001-12-13
BR0111292A (en) 2003-06-10
EP1289532A2 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
WO2001093831A3 (en) Low carbohydrate compositions, kits thereof, and methods of use
KR960036932A (en) Trehalose high syrup
BRPI0503981A (en) low calorie sugar substitute with water-insoluble bulking agent
ES2269943T5 (en) Highly branched soluble glucose polymers and their process of obtaining
CA2261597A1 (en) Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
KR950703327A (en) Ranitidine Chewable Tablets
BRPI0620042B8 (en) available low glycemic carbohydrate composition, liquid nutritional composition, and use of a carbohydrate composition
WO2002014252A3 (en) Compositions containing hypoglycemically active stilbenoids
US5869461A (en) Reducing toxicity of L-nucleosides with D-nucleosides
ES2055270T3 (en) USE OF L-SUGARS FOR THE MANUFACTURE OF LAXANT COMPOSITIONS.
TR199802394A2 (en) Developed process to stabilize proteins.
WO2002013811A3 (en) Compositions containing hypoglycemically active stilbenoids
KR940003547A (en) Antacid
TW580391B (en) Sulfated oligosaccharides having anticoagulant/antithrombotic activity
DK0472531T3 (en) Composition based on proanthocyanidols and their pharmacological use
SG10201803202WA (en) Sweetener composition
MY122723A (en) Derivatives of monosaccharides as cell adhesion inhibitors
BRPI0412588A (en) sweetener compositions with a sweetness profile and taste comparable to hfcs 55
ES2095658T3 (en) COMPOSITION FOR THE CONTROLLED RELEASE OF AN ACTIVE SUBSTANCE AND METHOD FOR THE PREPARATION OF SUCH COMPOSITION.
RU2000121989A (en) PHARMACEUTICAL COMPOSITIONS
PT1213972E (en) COMPOSITION COMPOSING AN ALPHA-AMYLASE INHIBITOR AND AT LEAST A PHYSIOLOGICALLY ACCEPTABLE COMPOUND ABLE TO REDUCE THE INTESTINAL ABSORPTION OF "QUICK ACUCARS"
BR1100612A (en) Suitable saccharide consisting of two saccharides and one spacer, their use and pharmaceutical composition
KR950703977A (en) CEREBRAL METABOLISM ACTIVATOR CONTAINING GLUCOSE ESTER DERIVATIVE
WO2006110491A3 (en) Complementary compositions to reduce blood glucose levels and treat diabetes
BR9915214A (en) Combinations containing a beta-agonist and an additional anti-diabetic agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2408610

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 501404

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/011939

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 018109829

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2001948259

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001948259

Country of ref document: EP